Ohio Public Employees Retirement System (OPERS)’s Indivior Pharmaceuticals INDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.98M Hold
72,527
– – 0.01% 913
2026
Q1
$2.21M Sell
72,527
-46,976
-39% -$1.55M 0.01% 1030
2025
Q4
$4.29M Sell
119,503
-13,575
-10% -$414K 0.01% 764
2025
Q3
$3.21M Buy
133,078
+89,002
+202% +$1.86M 0.01% 887
2025
Q2
$655K Sell
44,076
-4,398
-9% -$51.2K ﹤0.01% 1446
2025
Q1
$454K Buy
48,474
+9,104
+23% +$95.7K ﹤0.01% 1499
2024
Q4
$505K Buy
39,370
+9,576
+32% +$98.5K ﹤0.01% 1507
2024
Q3
$294K Buy
+29,794
New +$349K ﹤0.01% 1494

Other funds holding INDV

Ohio Public Employees Retirement System (OPERS)'s INDV Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) held its Indivior Pharmaceuticals (INDV) position steady in Q2 2026 at 72,527 shares worth $2.98M. The position accounts for 0.01% of the portfolio, ranked #913.

Ohio Public Employees Retirement System (OPERS) first reported a position in INDV in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.29M in Q4 2025. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) held 72,527 shares of Indivior Pharmaceuticals worth $2.98M as of Q2 2026.
  • Ohio Public Employees Retirement System (OPERS) left its Indivior Pharmaceuticals share count unchanged in Q2 2026.
  • Indivior Pharmaceuticals made up 0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #913 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Indivior Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Indivior Pharmaceuticals position peaked at $4.29M in Q4 2025.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.